These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 17996665)

  • 1. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies for the treatment of hematologic malignancies: schedule and maintenance therapy.
    Moccia A; Ghielmini M
    Semin Hematol; 2008 Apr; 45(2):75-84. PubMed ID: 18381101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
    Bross PF; Beitz J; Chen G; Chen XH; Duffy E; Kieffer L; Roy S; Sridhara R; Rahman A; Williams G; Pazdur R
    Clin Cancer Res; 2001 Jun; 7(6):1490-6. PubMed ID: 11410481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hematological malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):358-66. PubMed ID: 17353625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteins in haematology].
    Clarenbach RE; Mey U
    Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alemtuzumab in the treatment of chronic lymphocytic leukemia.
    Robak T
    BioDrugs; 2005; 19(1):9-22. PubMed ID: 15691213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy.
    Koo S; Baden LR
    J Natl Compr Canc Netw; 2008 Feb; 6(2):202-13. PubMed ID: 18319052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alemtuzumab (Campath 1-H).
    Schaal AD
    Clin J Oncol Nurs; 2005 Oct; 9(5):630-2. PubMed ID: 16235592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody therapy of leukaemias and lymphomas.
    Jacobs SA; Foon KA
    Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-targeted chemotherapy with immunoconjugates of calicheamicin.
    Damle NK
    Expert Opin Biol Ther; 2004 Sep; 4(9):1445-52. PubMed ID: 15335312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignancies.
    Shor B; Gerber HP; Sapra P
    Mol Immunol; 2015 Oct; 67(2 Pt A):107-16. PubMed ID: 25304309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies in hematology in 2009].
    Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G
    Rev Med Liege; 2009; 64(5-6):268-73. PubMed ID: 19642457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):323-9. PubMed ID: 12113055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gemtuzumab ozogamicin and targeted cancer therapy].
    Imaizumi M
    Nihon Yakurigaku Zasshi; 2004 Jul; 124(1):25-9. PubMed ID: 15226619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab.
    Ravandi F; O'Brien S
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):39-51. PubMed ID: 15757437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Magic bullets"--monoclonal antibodies in acute leukemia and non-Hodgkin's lymphoma treatment].
    Łuczyński W; Krawczuk-Rybak M
    Postepy Hig Med Dosw; 2002; 56(6):789-801. PubMed ID: 12669700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of CD20 monoclonal antibody therapy in B-cell malignancies.
    Czuczman MS; Gregory SA
    Leuk Lymphoma; 2010 Jun; 51(6):983-94. PubMed ID: 20367564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibodies in the treatment of non-Hodgkin's lymphoma.
    Bhat SA; Czuczman MS
    Neth J Med; 2009 Sep; 67(8):311-21. PubMed ID: 19767657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.